PubMed:26215578 / 163-306
Annnotations
c_corpus
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T30 | 0-3 | Q95ND4 | denotes | EGF |
T32 | 0-3 | PR:P01133 | denotes | EGF |
T33 | 0-3 | P01133 | denotes | EGF |
T34 | 0-3 | PR:P07522 | denotes | EGF |
T35 | 0-3 | PR:P01132 | denotes | EGF |
T36 | 0-3 | Q9BEA0 | denotes | EGF |
T37 | 0-3 | P01132 | denotes | EGF |
T38 | 0-3 | P07522 | denotes | EGF |
T40 | 0-3 | PR:000006928 | denotes | EGF |
T41 | 0-3 | P26224 | denotes | EGF |
T43 | 0-3 | Q00968 | denotes | EGF |
T31 | 0-3 | CHEBI:140739 | denotes | EGF |
T42 | 0-3 | D004815 | denotes | EGF |
T44 | 0-3 | D004815 | denotes | EGF |
T39 | 0-3 | GO:0005154 | denotes | EGF |
T45 | 15-22 | CHEBI:52214 | denotes | ligands |
T46 | 56-62 | UBERON:0000310 | denotes | breast |
T47 | 56-69 | D001943 | denotes | breast cancer |
T48 | 56-69 | D001943 | denotes | breast cancer |
T49 | 127-130 | Q95ND4 | denotes | EGF |
T51 | 127-130 | PR:P01133 | denotes | EGF |
T52 | 127-130 | P01133 | denotes | EGF |
T53 | 127-130 | PR:P07522 | denotes | EGF |
T54 | 127-130 | PR:P01132 | denotes | EGF |
T55 | 127-130 | Q9BEA0 | denotes | EGF |
T56 | 127-130 | P01132 | denotes | EGF |
T57 | 127-130 | P07522 | denotes | EGF |
T59 | 127-130 | PR:000006928 | denotes | EGF |
T60 | 127-130 | P26224 | denotes | EGF |
T62 | 127-130 | Q00968 | denotes | EGF |
T50 | 127-130 | CHEBI:140739 | denotes | EGF |
T61 | 127-130 | D004815 | denotes | EGF |
T63 | 127-130 | D004815 | denotes | EGF |
T58 | 127-130 | GO:0005154 | denotes | EGF |
DisGeNET5_gene_disease
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
26215578-0#0#10#gene2069 | 0-143 | gene2069 | denotes | EGF) family of ligands has been implicated in promoting breast cancer initiation, growth and progression. The contributions of EGF family ligan |
26215578-2#21#24#gene1950 | 127-130 | gene1950 | denotes | EGF |
26215578-2#21#24#gene1950 | 127-130 | gene1950 | denotes | EGF |